title: Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation?
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Tashiro
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Itamoto
authors.forename: Hideki
authors.initials: H
authors.lastname: Ohdan
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Fudaba
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Kohashi
authors.forename: Hironobu
authors.initials: H
authors.lastname: Amano
authors.forename: Kohei
authors.initials: K
authors.lastname: Ishiyama
authors.forename: Shoichi
authors.initials: S
authors.lastname: Takahashi
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Aikata
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Chayama
authors.forename: Koji
authors.initials: K
authors.lastname: Arihiro
authors.forename: Toshimasa
authors.initials: T
authors.lastname: Asahara
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000601:surgery*; D006801:Humans; D016031:Liver Transplantation; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012008:Recurrence; D013156:Splenectomy; D015996:Survival Rate; D013921:Thrombocytopenia / Q000209:etiology / Q000601:surgery; D016896:Treatment Outcome